International Journal of Biomedical Engineering Research


Cervical cancer: applications of genotyping for the screening in human papilomavirus (HPV)

Research article of International Journal of Biomedical Engineering Research Cervical cancer: applications of genotyping for the screening in human papilomavirus (HPV) Silva, V.M1; Santos, G.S2; Silva J.F.S3; Nascimento, E.R.S4; Wanderley, M.C.A5; Godone, R.L.N6 1,2,3,4Estudante do Curso de Biomedicina- UNINASSAU- Caruaru; 5,6Docente do curso de Biomedicina- UNINASSAU- Caruaru Introduction: Cervical cancer is considered a serious public health problem, especially in underdeveloped countries. The causal factor of the disease is infection of the vaginal mucosa by human papillomavirus (HPV). HPV consists of more than 130 genotypes, the genotypes of higher prevalence in histopathological diagnoses are subtypes 16 and 18. Currently diagnostic techniques such as pap smears and HPV test do not cover viral subtypes, important for identifying the presence of the high-risk genotypes in the sample, stopping the progression to cervical cancer. Genotyping consists of the secondary screening method for identification of viral subtypes, bringing promising prospects for the early diagnosis of the disease. Objective: To evaluate genotyping as an alternative for the early identification of the high risk HPV genotype as a possibility for the prevention of cervical cancer. Methodology: Electronic data platforms (MEDLINE, PubMed and Scopus) were consulted from 2012 to 2016, using the descriptors: “cervical cancer”, “HPV” and “genotyping”. Results and Discussion: With the applications of genotyping, it is possible to detect elements that indicate the presence of high-risk HPV subtypes in the positive samples in the initial screening techniques. Through the detection of the p16 and ki-67 proteins, which are expressed in the stages of the cell cycle, the decrease of these biomarkers indicates a deregulation in the cellular proliferation, indicating the oncogenic manifestation. The advancement of technologies has contributed to add improvements to screening programs and thus make them more effective in detecting women who have a greater potential for progression to cervical cancer. Conclusion: Although several techniques ...

The role of inflammatory mediators in carcinogenesis

Research article of International Journal of Biomedical Engineering Research The role of inflammatory mediators in carcinogenesis Silva M.R.P.1; Marcelino Neto P.P.2; Soares C.L.R.2; Lucena C.C.O.3; Correia J.C.A.1; Silva T.G.4 1Undergraduate student of the Biological Sciences Course of the Federal University of Pernambuco-UFPE; 2Graduate Student in Biological Sciences, Federal University of Pernambuco- UFPE; 3Graduate student in Pharmaceutical Sciences, Federal University of Pernambuco - UFPE; 4Professor/ Researcher of the Department of Antibiotics of the Federal University of Pernambuco- UFPE. Introduction: The process of carcinogenesis or tumor progression occurs slowly, which may take years until the formation of a visible tumor or an accumulation of abnormal, undifferentiated progenitor cells. Inflammation is a protective response of the body triggered by noxious stimuli. Studies report that the relationship between cancer and inflammation consists of the presence of inflammatory cells and inflammatory mediators in tumor tissues and angiogenesis. The inflammatory state contributes to tumor development through mechanisms such as: induction of genomic instability, stimulation of proliferation and resistance to apoptosis and induction of tumor angiogenesis. Objective: Introduce the most recent on the subject in the academic debate. Methodology: A bibliographical survey was carried out of the main academic journals with articles from the last five years. Results and Discussion: Studies have shown the frequent appearance of tumors in sites of chronic inflammation, besides the presence of inflammatory cells and mediators in tumor tissues, such as chemokines, cytokines and cyclooxygenase (COX), an enzyme responsible for the formation of important mediators including prostaglandins. Chemokine receptors are primarily responsible for leukocyte migration during inflammation and carcinogenesis, directly involved in the invasion, motility and survival of tumor cells. In relation to cytokines, TNF-α (tumor necrosis factor) stimulates growth. The presence of elevated serum levels of IL-6 in cancer patients was also observed. At the enzyme level, COX-2 overexpression is associated with ...

Dr.Prakash.MMS.Kinthada
Professor, Department Of Chemistry, Sri Vidya Nikethan Engineering College.Tirupathi ,INDIA

Dr. Kshitij Shinghal
Associate Professor and Dean Academics, MIT Mordabad, Uttar Pradesh

Dr. Shahin Gavanji
Chairman of “WAMS National Council of Iran at World Academy of Medical Sciences (WAMS), Chairman WAMS Oncology Research Group of Iran, Young Researchers and Elite Club, Khorasgan Branch, Islamic Azad University, Khorasgan, Isfahan, Iran, Department of Biotechnology, Faculty of Advanced Sciences and Technologies, University of Isfahan, Isfahan, Iran

Dr. Ashish Kumar
Associate Professor ,Department of Chemistry, HOD-Chemistry-School of Civil Engineering, HOD-Chemistry-School of Mechanical Engineering, HOD-Chemical Engineering and CHM-Petroleum Engineering, School of Chemical engineering and Physical Sciences, Lovely Faculty of Technology and Sciences, Lovely Professional University

Dr. Praveen Kumar Sharma
Associate Professor, Department of Chemistry, Lovely Professional University

Dr. Siamak Hoseinzadeh
West Tehran Branch, Islamic Azad University, Tehran, Iran

Manuscript Title: The title should be a brief phrase.

Author Information: List full names and affiliation of all authors, including Emails and phone numbers of corresponding author.

Abstract: The abstract should be less than 500 words. Following abstract, a list of keywords and abbreviations should be added. The keywords should be no more than 10. Abbreviation are only used for non standard and long terms.

Introduction: The introduction should included a clear statement of current problems.

Materials and Methods: This section should be clearly described.

Results and discussion: Authors may put results and discussion into a single section or show them separately.

Acknowledgement: This section includes a brief acknowledgment of people, grant details, funds

References: References should be listed in a numbered citation order at the end of the manuscript. DOIs and links to referenced articles should be added if available. Abstracts and talks for conferences or papers not yet accepted should not be cited. Examples Published Papers: 

1.Kaouthar Samarat, Sho Hanida, Shigeru Ishikawa, Kazunori Kotani, Teruo Matsuzawa.Detailed Computation of Air-Conditioning Modality within Chimpanzee Nasal Airways.International Journal of Biomedical Engineering Research, 2018, 2:6. DOI: 10.28933/ijber-2018-06-1901 
2.Borba A.D.L; Barbosa J.A.P; Santana M.A.N; Coutinho L.L; Farias L.O; Silva T.G. Evaluation of antioxidant and gastroprotective activities of ethyl acetate extract of Avicennia schaueriana.International Journal of Biomedical Engineering Research, 2018, 1:5. DOI: 10.28933/ijber-2018-05-1805

Tables and figures: Tables should be used at a minimum with a short descriptive title. The preferred file formats for Figures/Graphics are GIF, TIFF, JPEG or PowerPoint.

Proofreading and Publication: A proof will be sent to the corresponding author before publication. Authors should carefully read the proof to avoid any errors and return the proof to the editorial office. Editorial office will publish the article shortly and send a notice to authors with the links of the paper.

Open Access

International Journal of Biomedical Engineering Research (ISSN:2637-6563; DOI:10.28933/IJBER) is a peer reviewed open access journal publishing research manuscripts, review articles, editorials, letters to the editor in Biomedical Engineering Research.

Peer Review

To ensure the quality of the publications, all submitted manuscripts will be peer-reviewed by invited experts in the field. The decisions of editors will be made based on the comments of the reviewers.

Rapid Publication

Time to first decision: within 2 days for initial decision without review, 18 days with review; Time to publication: Accepted articles will be published online within 2 days, and final corrected versions by authors will be accessible within 5 days.  More details....

Rapid Response Team

Please feel free to contact our rapid response team if you have any questions. Our customer representative will answer you shortly.

International Journal of Biomedical Engineering Research

Upload

Note: Please compress all documents (manuscript, cover letter et al.,. ) into one .Zip file and then upload the Zip file.